EL THINK TANK " SWISS POLICY RESEARCH ". ES DIRECTO Y REFINADO. SU EVALUACION DE COMO LIQUIDAR EL "el bichito 19 EN MENOS DE 9 LINEAS+ JORGUE GUERRA LECT

allseeyingeye

Será en Octubre
Desde
3 Dic 2007
Mensajes
68.301
Reputación
37.589
Swiss Policy Research Logo


Swiss Policy Research (SPR), founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics and receives no external funding.


Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been tras*lated into more than two dozen languages.




On the treatment of el bichito-19

Published: July 2, 2020; Updated: July 30, 2020
Languages: DE, EN; Share on: Twitter / Facebook
Immunological and serological studies show that most people develop no symptoms or only mild symptoms when infected with the new cobi19, while some people may experience a more pronounced or critical course of the disease.
Based on the available scientific evidence and current clinical experience, the SPR Collaboration recommends that physicians and authorities consider the ***owing el bichito-19 treatment protocol for the early treatment of people at high risk or high exposure (see references below).
Based on this and very similar protocols, US physicians reported an 84% decrease in hospitalization rates, a 50% decrease in mortality rates among already hospitalized patients (if treated early), and an improvement in the condition of patients often within hours.




Note: Patients are asked to consult a doctor.

Treatment protocol
  1. Zinc (75mg to 100mg per day)
  2. Hydroxychloroquine (400mg per day)
  3. Quercetin (500mg to 1000mg per day)
  4. Azithromycin (up to 500mg per day)
  5. Heparin (usual dosage)






The primary component is zinc, which inhibits RNA polymerase activity of coronaviruses and thus blocks bichito replication (see references below). Hydroxychloroquine and quercetin support the cellular absorption of zinc. Azithromycin prevents bacterial superinfections. Heparin prevents infection-related thromboses and embolisms in patients at risk.
Note: Quercetin may be used in addition to or as a replacement of HCQ. Contraindications for HCQ (e.g. favism or heart problems) and azithromycin must be observed.​

Additional notes
The early treatment of patients as soon as the first typical symptoms appear and even without a PCR test is essential to prevent progression of the disease. Zinc, HCQ and quercetin may also be used prophylactically for people at high risk or high exposure (e.g. for health care workers).
In contrast, isolating infected high-risk patients at home and without early treatment until they develop serious respiratory problems, as often happened during lockdowns, may be detrimental.
The alleged or actual negative results with hydroxychloroquine in some studies were based on delayed use (intensive care patients), excessive doses (up to 2400mg per day), manipulated data sets (the Surgisphere scandal), or ignored contraindications (e.g., favism or heart disease).
Early treatment based on the above protocol is intended to avoid hospitalization. If hospitalization nevertheless becomes necessary, experienced ICU doctors recommend avoiding invasive ventilation (intubation) whenever possible and using oxygen therapy (HFNC) instead.
It is conceivable that the above treatment protocol, which is simple, safe and inexpensive, could render more complex medications, vaccinations, and other measures largely obsolete.​
Background
The fact that HCQ is effective against infections with SARS coronaviruses was already established in 2005 in the course of the SARS-1 epidemic. That zinc blocks the RNA replication of coronaviruses was discovered in 2010 by Ralph Baric, one of the world’s leading SARS virologists. That HCQ supports the cellular uptake of zinc was discovered in 2014 in the context of cancer research. That the flavonoid quercetin also supports the cellular uptake of zinc was also discovered in 2014.






















BONUS TRACK.

LECTURA COMENTADA

DE OTRO
ARTICULO DEL THINK TANK

SWISS POLICY RESEARCH

POR PEDRO GUERRA





Jorge Guerra
102.000 suscriptores

Texto completo con más datos y enlaces: https://swprs.org/hechos-sobre-el bichito-19/ Si te gusta mi trabajo y quieres apoyarlo puedes hacer donación a través de PayPal: https://www.paypal.me/canaljorgeguerra Conviértete en mecenas de este canal. Accede a la comunidad de patrocinadores y obtén a cambio exclusivas: https://www.patreon.com/jorgeguerra



 
Última edición:
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Última edición:
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
La OMS desaconseja el uso general de mascaras en niños de 6 a 11 años

zentauroepp54052134-soc200709181957-1594311825535.jpg
 
Volver